Stock Market

Pfizer, Gilead, GSK will dominate the infectious disease market

matdesign24/iStock via Getty Images

Pfizer (NYSE:PFE), Gilead Sciences (GILD) and GSK (GSK) are in a position to control a large part of the infectious disease treatment market due to increased demand for COVID-19 drugs and HIV treatments.

That’s the assessment of analytics and consulting firm GlobalData, which estimates a CAGR for the market of 5.7% between 2023 and 2029.

Related Articles

Back to top button